Clinical trial
A Phase I Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib (BSI-201) in Multiple Non Operable Brain Metastases
NCT01551680 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib (BSI-201) in Multiple Non Operable Brain Metastases
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- September 30, 2012
- Completion date
- February 28, 2014
- Enrollment
- 3 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastases